Rights and permissions
About this article
Cite this article
Cost of implementing UKPDS results in type 2 DM feasible. Pharmacoecon. Outcomes News 386, 8 (2002). https://doi.org/10.1007/BF03279792
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279792